Eli Lilly announces positive top-line results from the TRAILBLAZER-ALZ2 trial of donanemab News 7 June, 2023 0Comments
U.S. gives full approval to Lecanemab to treat Alzheimer’s disease and will fund its use News 17 April, 2023 0Comments
Effects of antidepressant treatment on cognition in patients with Alzheimer’s disease News 13 April, 2023 0Comments
Rare missense variant on APOE counterbalances the Alzheimer’s disease risk associated with APOE‐ε4 News 11 January, 2023 0Comments
Antidepressant tianeptine shows cognitive benefits in Alzheimer’s disease patients News 2 December, 2022 0Comments
Rare missense variants on APOE can result in substantial risk reduction for AD News 20 June, 2022 0Comments
